Animal models of Parkinson's disease. (Q34596189): Difference between revisions

From Wikidata

Jump to navigation Jump to search

Browse history interactively

← Older edit Newer edit →

Revision as of 02:28, 26 June 2020

scientific article

Language	Label	Description	Also known as
English	Animal models of Parkinson's disease.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

Europe PubMed Central

Animal models of Parkinson's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Parkinson's disease

1 reference

based on heuristic

J. Timothy Greenamyre

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

Ranjita Betarbet

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Todd B Sherer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

0 references

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

308-318

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11948617%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Anatomical and chemical studies of a nigro-neostriatal projection in the cat.

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

The functional anatomy of basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Neural mechanisms in disorders of movement.

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Primate models of movement disorders of basal ganglia origin

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

A Drosophila model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

NMDA-dependent superoxide production and neurotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Mechanisms of action of 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

6-hydroxy-dopamine induced degeneration of central monoamine neurons

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

A 6-hydroxydopamine-induced selective parkinsonian rat model

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. II. Bilateral lesions

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Pesticides and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Creatine and cyclocreatine attenuate MPTP neurotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Bioenergetics and glutamate excitotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Novel free radical spin traps protect against malonate and MPTP neurotoxicity.

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Protein nitration in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. The European Consortium on Genetic Susceptibility in Parkinson's Disease and the French Parkinson's Disease Genetics Study Gro

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Transgenic models of tauopathies and synucleinopathies

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

The ubiquitin pathway in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10067

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34596189&oldid=1216701884"